Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04512209
What this trial is testing

Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology

Who this might be right for
Carcinomatosis, PeritonealPancreas CancerOvarian Cancer+1 more
University Hospital, Ghent 22
Not applicableStudy completedNCT00564265
What this trial is testing

Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo

Who this might be right for
Gastrointestinal Stromal Tumors
Cirujanos la Serena 24
Not applicableLooking for participantsNCT05751733
What this trial is testing

Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Xiangya Hospital of Central South University 258
Early research (Phase 1)Study completedNCT00441155
What this trial is testing

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 14
Large-scale testing (Phase 3)Looking for participantsNCT07585266
What this trial is testing

Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

Who this might be right for
Gastrointestinal Stromal Neoplasms
GlaxoSmithKline 800
Testing effectiveness (Phase 2)Study completedNCT02606097
What this trial is testing

Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation

Who this might be right for
Gastrointestinal Stromal Tumour (GIST)
Chang Gung Memorial Hospital 19
Not applicableUnknownNCT02776878
What this trial is testing

A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST

Who this might be right for
Gastrointestinal Stromal Tumor
Peking University Cancer Hospital & Institute 57
Early research (Phase 1)Study completedNCT03291288
What this trial is testing

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Who this might be right for
Drug Interaction Potential
Daiichi Sankyo 32
Testing effectiveness (Phase 2)UnknownNCT02365441
What this trial is testing

A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)

Who this might be right for
Gastrointestinal Stromal Tumour
Australasian Gastro-Intestinal Trials Group 78
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Very early researchStudy completedNCT04006769
What this trial is testing

Entacapone Combination With Imatinib for Treatment of GIST

Who this might be right for
Gastrointestinal Stromal Tumor, Malignant
Xiangya Hospital of Central South University 5
Not applicableUnknownNCT03082079
What this trial is testing

Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)

Who this might be right for
GIST
Nanfang Hospital, Southern Medical University 90
Not applicableLooking for participantsNCT07697248
What this trial is testing

LRG GIST Patient Registry

Who this might be right for
GISTGIST - Gastrointestinal Stromal TumorGastrointestinal Stromal Tumor (GIST)
The Life Raft Group 5,000
Testing effectiveness (Phase 2)Ended earlyNCT00091078
What this trial is testing

Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Stromal Tumor
National Cancer Institute (NCI) 96
Not applicableNo Longer AvailableNCT04714086
What this trial is testing

Expanded Access Program for Avapritinib

Who this might be right for
Solid Tumors
Blueprint Medicines Corporation
Not applicableStudy completedNCT01170299
What this trial is testing

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

Who this might be right for
Anal CancerBladder CancerCervical Cancer+6 more
Royal Marsden NHS Foundation Trust 177
Not applicableStudy completedNCT03123432
What this trial is testing

Immunomodulating Nutrients in Perioperative Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital 34
Large-scale testing (Phase 3)Study completedNCT01271712
What this trial is testing

Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer 199
Testing effectiveness (Phase 2)Ended earlyNCT03165721
What this trial is testing

A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer

Who this might be right for
ParagangliomaGastrointestinal Stromal TumorsCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT04254939
What this trial is testing

CS3007 in Subjects With Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumors
CStone Pharmaceuticals 65
Next Page